Short-term maraviroc exposure, a clinical approach to decide on maraviroc prescription in HIV-1-infected treatment-naïve patients.

Gonzalez-Serna, AlejandroGenebat, MiguelRuiz-Mateos, EzequielLeal, Manuel2023-01-252023-01-252016-01-18http://hdl.handle.net/10668/9810enAttribution-NonCommercial 4.0 Internationalhttp://creativecommons.org/licenses/by-nc/4.0/AnimalsCCR5 Receptor AntagonistsCyclohexanesHIV Fusion InhibitorsHIV InfectionsHIV-1HumansTriazolesShort-term maraviroc exposure, a clinical approach to decide on maraviroc prescription in HIV-1-infected treatment-naïve patients.research article26848259open access10.2147/DDDT.S1006391177-8881PMC4723024https://www.dovepress.com/getfile.php?fileID=28659https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723024/pdf